COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Time Restricted Feeding in Autosomal Dominant Polycystic Kidney Disease

Not Applicable

Completed

Conditions: Polycystic Kidney, Autosomal Dominant

Interventions: Behavioral: Dietary

First Posted Date: 2020-09-01

Last Posted Date: 2023-04-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 29

Registration Number: NCT04534985

Locations: 🇺🇸
University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States

Virtual Exercise Program to Reduce Cancer Related Fatigue

Not Applicable

Active, not recruiting

Conditions: Fatigue
Cancer-related Problem/Condition
Cancer

Interventions: Behavioral: Exercise

First Posted Date: 2020-08-31

Last Posted Date: 2024-08-22

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 19

Registration Number: NCT04533165

Locations: 🇺🇸
Anschutz Health and Wellness, Aurora, Colorado, United States

Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine

Early Phase 1

Completed

Conditions: Platelet-Rich Plasma

Interventions: Biological: Autologous platelet rich plasma

First Posted Date: 2020-08-21

Last Posted Date: 2022-05-04

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 5

Registration Number: NCT04522674

Locations: 🇺🇸
University of Colorado School of Medicine Spine Center, Aurora, Colorado, United States

CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr

Phase 2

Active, not recruiting

Conditions: Autism Spectrum Disorder

Interventions: Drug: Oral cannabidiol 100mg/mL
Drug: Placebo

First Posted Date: 2020-08-20

Last Posted Date: 2024-05-08

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 86

Registration Number: NCT04520685

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Pilot Trial of Hypnosis and Enhanced Communication In Patients Undergoing MRI

Not Applicable

Completed

Conditions: Magnetic Resonance Imaging
Claustrophobia
Anxiety

Interventions: Behavioral: Care by technician trained in empathic communication
Behavioral: Clinical Hypnosis performed by the PI

First Posted Date: 2020-08-20

Last Posted Date: 2022-05-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 40

Registration Number: NCT04520100

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

STRENGTH Expansion

Withdrawn

Conditions: Gastroesophageal Junction Cancer
Esophageal Cancer

Interventions: Other: STRENGTH

First Posted Date: 2020-08-20

Last Posted Date: 2021-11-24

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT04520867

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Modifications of Devices for Hip Arthroscopy

Not Applicable

Conditions: Hip Arthroscopy

Interventions: Device: Modified hip capsule side fixed slotted cannula
Device: Modified bone graft delivery tool set

First Posted Date: 2020-08-18

Last Posted Date: 2023-02-08

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 111

Registration Number: NCT04516109

Locations: 🇺🇸
UCHealth Steadman Hawkins Clinic - Denver, Englewood, Colorado, United States
🇺🇸
University of Colorado, Hip Preservation Center, Orthopedic Department, Boulder, Colorado, United States

A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures

Not Applicable

Recruiting

Conditions: Epilepsy

Interventions: Device: OPM sensors
Device: SQUID sensors

First Posted Date: 2020-08-17

Last Posted Date: 2024-05-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 40

Registration Number: NCT04515316

Locations: 🇺🇸
University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, Colorado, United States

The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss

Recruiting

Conditions: Hearing Loss, Central
Healthy Individuals

First Posted Date: 2020-08-14

Last Posted Date: 2023-08-15

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 200

Registration Number: NCT04513782

Locations: 🇺🇸
University of Colorado School of Medicine, Aurora, Colorado, United States

Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma

Phase 2

Completed

Conditions: Follicular Lymphoma
Marginal Zone Lymphoma

Interventions: Drug: Ublituximab
Drug: Umbralisib

First Posted Date: 2020-08-11

Last Posted Date: 2024-03-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 4

Registration Number: NCT04508647

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy